Literature DB >> 1966052

Enkephalins modulate inhibitory neuromuscular transmission in circular muscle of human colon via delta-opioid receptors.

C H Hoyle1, M A Kamm, G Burnstock, J E Lennard-Jones.   

Abstract

1. A sucrose-gap technique was used to investigate the neuromodulatory actions of enkephalins on non-adrenergic, non-cholinergic inhibitory junction potentials (IJPs) in the circular muscle of the human large intestine. 2. The native enkephalins, [Leu5]enkephalin (LENK) and [Met5]enkephalin (MENK) caused a concentration-dependent reduction in amplitude of IJPs without a significant effect on the smooth muscle membrane. 3. The actions of LENK and MENK were mimicked by the delta-selective opioid receptor agonists [D-Pen2, D-Pen5]enkephalin (DPDPE) and [D-Ala2, D-Leu5]enkephalin (DADLE). 4. The actions of LENK, MENK and DPDPE were antagonized to similar extents by the delta-selective opioid receptor antagonist ICI 174,864. 5. The mu-selective opioid receptor agonist [D-Ala2, Me Phe, Gly-ol5]enkephalin was approximately 100-fold less potent than any of the native or synthetic enkephalins at reducing the amplitude of the IJP. Dynorphin A and beta-endorphin both had very weak activity. 6. Responses to all of the agonists were inhibited by naloxone. The degree of antagonism of DPDPE or DADLE by naloxone (1 microM) was the same as that of LENK or MENK. 7. Neither MENK nor LENK affected hyperpolarization of the smooth muscle membrane induced by ATP or 5-hydroxytryptamine. Vasoactive intestinal polypeptide (1 pM-1 microM) did not produce any observable responses and this lack of reactivity was not affected by the enkephalins. 8. It is concluded that in the circular muscle of the human colon, LENK and MENK can act on prejunctional delta-opioid receptors to produce inhibition of non-adrenergic, non-cholinergic inhibitory neuromuscular transmission. Possible physiological significance of this prejunctional receptor is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1966052      PMCID: PMC1181784          DOI: 10.1113/jphysiol.1990.sp018340

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  54 in total

1.  [Met5]enkephalin acts via delta-opioid receptors to inhibit pelvic nerve-evoked contractions of cat distal colon.

Authors:  C Kennedy; J Krier
Journal:  Br J Pharmacol       Date:  1987-10       Impact factor: 8.739

2.  Projections of peptide-containing neurons in rat small intestine.

Authors:  E Ekblad; C Winther; R Ekman; R Håkanson; F Sundler
Journal:  Neuroscience       Date:  1987-01       Impact factor: 3.590

3.  Autoradiographic localization of delta-opioid binding sites in human sigmoid colon.

Authors:  S James; C H Hoyle; G Burnstock; J R Jass; I J Jeffrey; J E Lennard-Jones
Journal:  Eur J Pharmacol       Date:  1987-10-06       Impact factor: 4.432

4.  Influence of metenkephalin analogue on motor activity of the gastrointestinal tract.

Authors:  R Jians; J Janssens; G Vantrappen; P Ceccatelli
Journal:  Gastroenterology       Date:  1987-07       Impact factor: 22.682

5.  A modified single sucrose gap. Junction potentials and electrotonic potentials in gastrointestinal smooth muscles.

Authors:  C H Hoyle
Journal:  J Pharmacol Methods       Date:  1987-11

6.  Nerves containing substance P, vasoactive intestinal polypeptide, enkephalin or somatostatin in the guinea-pig taenia coli. Distribution, ultrastructure and possible functions.

Authors:  S Leander; R Håkanson; F Sundler
Journal:  Cell Tissue Res       Date:  1981       Impact factor: 5.249

7.  Naloxone in irreversible shock.

Authors:  M Tiengo
Journal:  Lancet       Date:  1980-09-27       Impact factor: 79.321

8.  The vagal control of the pyloric motor function: a physiological and immunohistochemical study in cat and man.

Authors:  R Edin
Journal:  Acta Physiol Scand Suppl       Date:  1980

9.  Role of opiate receptors in the regulation of colonic transit.

Authors:  P N Kaufman; B Krevsky; L S Malmud; A H Maurer; M B Somers; J A Siegel; R S Fisher
Journal:  Gastroenterology       Date:  1988-06       Impact factor: 22.682

10.  Distribution and quantitation of gut neuropeptides in normal intestine and inflammatory bowel diseases.

Authors:  T R Koch; J A Carney; V L Go
Journal:  Dig Dis Sci       Date:  1987-04       Impact factor: 3.199

View more
  8 in total

1.  Effect of a novel prokinetic drug, R093877, on gastrointestinal transit in healthy volunteers.

Authors:  A V Emmanuel; M A Kamm; A J Roy; K Antonelli
Journal:  Gut       Date:  1998-04       Impact factor: 23.059

2.  Inflammation-associated changes in DOR expression and function in the mouse colon.

Authors:  Jesse J DiCello; Ayame Saito; Pradeep Rajasekhar; Emily M Eriksson; Rachel M McQuade; Cameron J Nowell; Benjamin W Sebastian; Jakub Fichna; Nicholas A Veldhuis; Meritxell Canals; Nigel W Bunnett; Simona E Carbone; Daniel P Poole
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-06-21       Impact factor: 4.052

3.  Regulation of neural responses in the canine pyloric sphincter by opioids.

Authors:  O Bayguinov; K M Sanders
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

4.  Light- and electron-microscopic immunochemical analysis of nerve fibre types innervating the taenia of the guinea-pig caecum.

Authors:  J B Furness; S Pompolo; C W Shuttleworth; D E Burleigh
Journal:  Cell Tissue Res       Date:  1992-10       Impact factor: 5.249

5.  An electrophysiological study of developmental changes in the innervation of the guinea-pig taenia coli.

Authors:  V P Zagorodnyuk; C H Hoyle; G Burnstock
Journal:  Pflugers Arch       Date:  1993-06       Impact factor: 3.657

6.  Electrophysiological evidence for different release mechanism of ATP and NO as inhibitory NANC transmitters in guinea-pig colon.

Authors:  V Zagorodnyuk; C A Maggi
Journal:  Br J Pharmacol       Date:  1994-08       Impact factor: 8.739

Review 7.  Purinergic signalling in the gastrointestinal tract and related organs in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-12-04       Impact factor: 3.765

8.  Methylnaltrexone in the treatment of opioid-induced constipation.

Authors:  Beverley Greenwood-Van Meerveld; Kelly M Standifer
Journal:  Clin Exp Gastroenterol       Date:  2008-12-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.